Reactions along the astrophysical s-process path and prospects for neutron radiotherapy with the Liquid-Lithium Target (LiLiT) at the Soreq Applied Research Accelerator Facility (SARAF)

Michael Paul*, Moshe Tessler, Moshe Friedman, Shlomi Halfon, Tala Palchan, Leonid Weissman, Alexander Arenshtam, Dan Berkovits, Yosef Eisen, Ilan Eliahu, Gitai Feinberg, Daniel Kijel, Arik Kreisel, Israel Mardor, Guy Shimel, Asher Shor, Ido Silverman

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Neutrons play a dominant role in the stellar nucleosynthesis of heavy elements and the quest for accurate experimental determinations of neutron-induced reaction cross sections becomes more stringent with the refinement of nuclear and astrophysical models. We review here an experimental nuclear-astrophysics program using a high-intensity neutron source based on the 7 Li(p, n) 7 Be reaction with a Liquid-Lithium Target (LiLiT) at the Soreq Applied Research Accelerator Facility (SARAF) Phase I. The quasi-Maxwellian neutron spectrum with effective thermal energy kT≈ 30 keV, characteristic of the thick-target 7 Li(p, n) yield at proton energy E p ≈ 1. 92 MeV close to its neutron threshold, is well suited for laboratory measurements of neutron capture reactions along the astrophysical s -process path. The high-intensity proton beam (in the mA range) of SARAF and the high power (few kW) dissipation of LiLiT result in the most intense source of neutrons available today at stellar-like energies. The principle, design and properties of the LiLiT device and recent measurements of Maxwellian Averaged Cross Sections (MACS) based on activation of targets of astrophysical interest are described. Decay counting or atom counting methods (accelerator mass spectrometry, atom-trap trace analysis) are used for the detection of short-lived or long-lived activation products, respectively. In a different realm of applications, the 7 Li(p, n) reaction is a leading candidate as an accelerator-based neutron source for Boron Neutron Capture Therapy (BNCT). The high neutron yield achievable from a liquid-lithium target, its sustainability of operation under kW-power incident beams and the recent availability of small-size high-intensity accelerators are compatible with a hospital-based clinical facility. An effort towards the characterization and realization of a liquid-lithium target for BNCT is reviewed. Perspectives of pending and future developments towards SARAF Phase II, based on a 40MeV, 5mA CW proton/deuteron superconducting linear accelerator, are summarized.

Original languageEnglish
Article number44
JournalEuropean Physical Journal A
Volume55
Issue number3
DOIs
StatePublished - 1 Mar 2019

Funding

FundersFunder number
Eshkol Foundation of Israel Ministry of Science and Technology
Israel Ministry of Science and Technology
Israel Science Foundation
PAZY Foundation

    Fingerprint

    Dive into the research topics of 'Reactions along the astrophysical s-process path and prospects for neutron radiotherapy with the Liquid-Lithium Target (LiLiT) at the Soreq Applied Research Accelerator Facility (SARAF)'. Together they form a unique fingerprint.

    Cite this